Atlas Trials

POINTING: Clinical Cohort Study of Patients With Melanoma and NSCLC Receiving Checkpoint Inhibitors

Clinical trial NCT04193956 · UNKNOWN

Trial details

NCT number
NCT04193956
Sponsor
University Medical Center Groningen
Status
UNKNOWN
Study type
OBSERVATIONAL
MelanomaNon-Small Cell Lung Cancer
Start date
2018-08-01
Primary completion
2024-09-01
Enrollment
3500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.